Article

Increased Blood Draws for Ultrasensitive ctDNA and CTCs Detection in Early Breast Cancer Patients

2023-11-20

Abstract excerpt

<title>Abstract</title> <p>Early breast cancer patients often experience relapse due to residual disease after treatment. Liquid biopsy is a methodology capable of detecting tumor components in blood, but low concentrations at early stages pose challenges. To detect them, next-generation sequencing has promise but entails complex processes. Exploring larger blood volumes could overcome detection limitations. Here...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a3bd854e-5e4b-5789-adc1-15f5b2b711e4
DOI: 10.21203/rs.3.rs-3556909/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Increased Blood Draws for Ultrasensitive ctDNA and CTCs Detection in Early Breast Cancer PatientsDOI 10.21203/rs.3.rs-3556909/v1Read

Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective.Semantic proximity Read

Liquid biopsy in early breast cancer. A preliminary reportSemantic proximity Read

Early-Stage Breast Cancer Detection in Breast Milk.Semantic proximity Read

Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA: It Is in the Blood.Semantic proximity Read

Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer Diagnosis.Semantic proximity Read

Development of a novel NGS methodology for ultrasensitive circulating tumour DNA detection as a tool for early-stage breast cancer diagnosisSemantic proximity Read

Comparative study of droplet-digital PCR and absolute Q digital PCR for ctDNA detection in early-stage breast cancer patients.Semantic proximity Read

Improvement of the sensitivity of circulating tumor DNA-based liquid biopsy: current approaches and future perspectivesSemantic proximity Read

Clinical Validation of Digital PCR-based ctDNA detection for risk stratification in residual triple negative breast cancer: TRICIA trial resultsSemantic proximity Read

Clinical application of circulating tumor DNA in breast cancer.Semantic proximity Read

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring.Semantic proximity Read

Circulating Tumor DNA in Breast Cancer: Current and Future Applications.Semantic proximity Read